Research and trials

Today, the UK National Screening Committee has recommended introducing a targeted lung cancer screening programme across the UK, for those…

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people – we explore its potential impact…

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

We dive into five innovations from the world’s greatest minds that could transform the way we deal with cancer

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

When it comes to diagnosing cancers early, screening is our best available tool. Cancer screening involves testing for early signs…

We’re unpacking two recently funded Cancer Grand Challenges, and introducing the global, multidisciplinary teams taking them on.

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

Despite big improvements in survival, cancer is still one of the world’s biggest killers. Leading scientists explain why it presents such a challenge – and look at how far we’ve come